Back to search

Article

Genome-Wide Meta-Analysis Validates a Role for <i>S1PR1</i> in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

2020-04-30

Abstract excerpt

Microtubule targeting agents (MTAs) are anticancer therapies commonly prescribed for breast cancer and other solid tumors. Sensory peripheral neuropathy (PN) is the major dose-limiting toxicity for MTAs and can limit clinical efficacy. The current pharmacogenomic study aimed to identify genetic variations that explain patient susceptibility and drive mechanisms underlying development of MTA-induced PN. A meta-anal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53a6a75e-2d14-5683-b074-8a12d892e3c3
DOI
10.1101/2020.04.23.20076208
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genome-Wide Meta-Analysis Validates a Role for <i>S1PR1</i> in Microtubule Targeting Agent-Induced Sensory Peripheral NeuropathyDOI 10.1101/2020.04.23.20076208
Select a neighboring publication to make it the new centre.